carbamates has been researched along with Anemia in 10 studies
Anemia: A reduction in the number of circulating ERYTHROCYTES or in the quantity of HEMOGLOBIN.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Our study demonstrated that liver transplant patients with a recurrence of hepatitis C who are initiating ribavirin combined with a sofosbuvir-daclatasvir direct-acting antiviral regimen may be at risk of lower tacrolimus concentrations because of probable ribavirin-induced anaemia and higher fibrosis score, although there are no effects on cyclosporine levels." | 3.91 | Comparison of the effect of direct-acting antiviral with and without ribavirin on cyclosporine and tacrolimus clearance values: results from the ANRS CO23 CUPILT cohort. ( Barrail-Tran, A; Botta-Fridlund, D; Cagnot, C; Canva, V; Coilly, A; Conti, F; D'Alteroche, L; Danjou, H; De Ledinghen, V; Duclos-Vallée, JC; Durand, F; Duvoux, C; Fougerou-Leurent, C; Gelé, T; Goldwirt, L; Houssel-Debry, P; Kamar, N; Laforest, C; Lavenu, A; Leroy, V; Moreno, C; Pageaux, GP; Radenne, S; Samuel, D; Taburet, AM, 2019) |
| " However, information about the rate of adverse events (AEs) across different DAA regimens is limited." | 2.87 | Outcome and adverse events in patients with chronic hepatitis C treated with direct-acting antivirals: a clinical randomized study. ( Andersen, ES; Bukh, J; Christensen, PB; Fahnøe, U; Gerstoft, J; Kjær, MS; Laursen, AL; Mössner, B; Pedersen, MS; Røge, BT; Schønning, K; Sølund, C; Weis, N, 2018) |
| "In the interferon era, the treatment of hepatitis C virus (HCV) infection in patients on haemodialysis (HD) was limited due to the significant number of treatment-related adverse events (AEs)." | 1.51 | Elimination of hepatitis C virus infection from a hemodialysis unit and impact of treatment on the control of anemia. ( Arias, M; Belmar, L; González, LN; Laguno, M; Llovet, LP; Londoño, MC; Maduell, F; Mallolas, J; Martínez-Rebollar, M; Ojeda, R; Rodas, L; Rossi, F; Ugalde, J, 2019) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (20.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (10.00) | 29.6817 |
| 2010's | 7 (70.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Wiegand, J | 1 |
| Buggisch, P | 1 |
| Mauss, S | 1 |
| Boeker, KHW | 1 |
| Klinker, H | 1 |
| Müller, T | 1 |
| Günther, R | 1 |
| Serfert, Y | 1 |
| Manns, MP | 1 |
| Zeuzem, S | 1 |
| Berg, T | 1 |
| Hinrichsen, H | 1 |
| C-Registry, GH | 1 |
| Cursino, CN | 1 |
| Monteiro, PGO | 1 |
| Duarte, GDS | 1 |
| Vieira, TBQ | 1 |
| Crisante, VC | 1 |
| Giordani, F | 1 |
| Xavier, AR | 1 |
| de Almeida, RMVR | 1 |
| Calil-Elias, S | 1 |
| Sølund, C | 1 |
| Andersen, ES | 1 |
| Mössner, B | 1 |
| Laursen, AL | 1 |
| Røge, BT | 1 |
| Kjær, MS | 1 |
| Gerstoft, J | 1 |
| Christensen, PB | 1 |
| Pedersen, MS | 1 |
| Schønning, K | 1 |
| Fahnøe, U | 1 |
| Bukh, J | 1 |
| Weis, N | 1 |
| Maduell, F | 1 |
| Belmar, L | 1 |
| Ugalde, J | 1 |
| Laguno, M | 1 |
| Martínez-Rebollar, M | 1 |
| Ojeda, R | 1 |
| Arias, M | 1 |
| Rodas, L | 1 |
| Rossi, F | 1 |
| Llovet, LP | 1 |
| González, LN | 1 |
| Mallolas, J | 1 |
| Londoño, MC | 1 |
| Barrail-Tran, A | 1 |
| Goldwirt, L | 1 |
| Gelé, T | 1 |
| Laforest, C | 1 |
| Lavenu, A | 1 |
| Danjou, H | 1 |
| Radenne, S | 1 |
| Leroy, V | 1 |
| Houssel-Debry, P | 1 |
| Duvoux, C | 1 |
| Kamar, N | 1 |
| De Ledinghen, V | 1 |
| Canva, V | 1 |
| Conti, F | 1 |
| Durand, F | 1 |
| D'Alteroche, L | 1 |
| Botta-Fridlund, D | 1 |
| Moreno, C | 1 |
| Cagnot, C | 1 |
| Samuel, D | 1 |
| Fougerou-Leurent, C | 1 |
| Pageaux, GP | 1 |
| Duclos-Vallée, JC | 1 |
| Taburet, AM | 1 |
| Coilly, A | 1 |
| Steinhardt, LC | 1 |
| Yeka, A | 1 |
| Nasr, S | 1 |
| Wiegand, RE | 1 |
| Rubahika, D | 1 |
| Sserwanga, A | 1 |
| Wanzira, H | 1 |
| Lavoy, G | 1 |
| Kamya, M | 1 |
| Dorsey, G | 1 |
| Filler, S | 1 |
| Kalim, S | 1 |
| Tamez, H | 1 |
| Wenger, J | 1 |
| Ankers, E | 1 |
| Trottier, CA | 1 |
| Deferio, JJ | 1 |
| Berg, AH | 1 |
| Karumanchi, SA | 1 |
| Thadhani, RI | 1 |
| Gamlin, J | 1 |
| Diaz Romo, P | 1 |
| Hesketh, T | 1 |
| Tatibana, M | 1 |
| Ito, K | 1 |
| Levina, MM | 1 |
| Kurando, TB | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Occult Hepatitis C Virus Infection In Hemodialysis Patients Who Achieved A Sustained Virological Response To Directly Acting Antiviral Drugs: Is It A Concern ?[NCT04719338] | 30 participants (Actual) | Interventional | 2021-03-01 | Completed | |||
| Cohort of Liver Transplanted Patients With Hepatitis C Virus Recurrence and Treated With Direct-acting Antiviral Agents[NCT01944527] | 699 participants (Actual) | Observational | 2013-10-31 | Active, not recruiting | |||
| Amino Acid Therapy to Modify Protein Carbamylation in End Stage Renal Disease: A Randomized Trial[NCT02472834] | 54 participants (Actual) | Interventional | 2016-02-29 | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 trial available for carbamates and Anemia
| Article | Year |
|---|---|
Outcome and adverse events in patients with chronic hepatitis C treated with direct-acting antivirals: a clinical randomized study.
Topics: 2-Naphthylamine; Adult; Anemia; Anilides; Antiviral Agents; Benzimidazoles; Carbamates; Cyclopropane | 2018 |
9 other studies available for carbamates and Anemia
| Article | Year |
|---|---|
Hepatitis C therapy with direct antiviral agents in patients with advanced chronic kidney disease: real-world experience of the German Hepatitis C-Registry (Deutsches Hepatitis C-Register).
Topics: 2-Naphthylamine; Acute Disease; Adult; Aged; Anemia; Anilides; Antiviral Agents; Benzimidazoles; Car | 2019 |
Predictors of adverse drug reactions associated with ribavirin in direct-acting antiviral therapies for chronic hepatitis C.
Topics: Adult; Aged; Aged, 80 and over; Anemia; Antiviral Agents; Brazil; Carbamates; Drug Therapy, Combinat | 2019 |
Elimination of hepatitis C virus infection from a hemodialysis unit and impact of treatment on the control of anemia.
Topics: 2-Naphthylamine; Anemia; Anilides; Antiviral Agents; Carbamates; Cyclopropanes; Darbepoetin alfa; Fe | 2019 |
Comparison of the effect of direct-acting antiviral with and without ribavirin on cyclosporine and tacrolimus clearance values: results from the ANRS CO23 CUPILT cohort.
Topics: Aged; Anemia; Antiviral Agents; Carbamates; Cyclosporine; Drug Interactions; Drug Therapy, Combinati | 2019 |
The effect of indoor residual spraying on malaria and anemia in a high-transmission area of northern Uganda.
Topics: Anemia; Carbamates; Child; Child, Preschool; Cross-Sectional Studies; Family Characteristics; Female | 2013 |
Carbamylation of serum albumin and erythropoietin resistance in end stage kidney disease.
Topics: Aged; Aged, 80 and over; Anemia; Biomarkers; Carbamates; Drug Resistance; Erythropoietin; Female; He | 2013 |
Exposure of young children working on Mexican tobacco plantations to organophosphorous and carbamic pesticides, indicated by cholinesterase depression.
Topics: Acetylcholinesterase; Adolescent; Agriculture; Anemia; Biomarkers; Carbamates; Child; Child, Prescho | 2007 |
Control of pyrimidine biosynthesis in mammalian tissues. I. Partial purification and characterization of glutamine-utilizing carbamyl phosphate synthetase of mouse spleen and its tissue distribution.
Topics: Adenosine Triphosphate; Anemia; Animals; Anura; Bicarbonates; Carbamates; Carbon Isotopes; Cattle; C | 1969 |
[Problems of industrial hygiene and the state of health of workers engaged in the production of isopropylphenylcarbamate].
Topics: Adult; Air Pollution; Anemia; Aniline Compounds; Blood Cells; Carbamates; Environmental Exposure; Fe | 1967 |